2025 AUGS Clinical Meeting-Bugs versus Drugs - Incorporating the Microbiome into Recurrent UTI Treatment

Bugs versus Drugs - Incorporating the Microbiome into Recurrent UTI Treatment

Video Transcription

Video Summary

The presentation focuses on the evolving approach to managing recurrent urinary tract infections (UTIs), emphasizing the dynamic relationship between the urinary microbiome and infection treatment. Traditionally, UTIs were treated with antibiotics, but new insights reveal that understanding and managing the microbiome is crucial. Key points include the importance of accurate UTI diagnosis, the limitations of standard urine cultures, and the potential use of molecular diagnostics for precision. The speaker highlights the significant changes in the microbiome during menopause, advocating for the use of vaginal estrogen to promote healthy microbial ecology in the urinary tract. Additionally, the role of probiotics, particularly those containing lactobacillus crispatus, is stressed for maintaining a beneficial microbial environment. The presentation suggests a shift from solely relying on antibiotics to a comprehensive approach that includes local ecology optimization for preventing recurrent infections, thereby enhancing patient outcomes.

Asset Subtitle

Attendees will learn about the best strategies for managing recurrent UTI, as well as the latest science on the urinary microbiome and how we can apply this information to the care of our patients.

Speaker - Nazema Y. Siddiqui, MD, MHSc

Keywords

urinary tract infections

urinary microbiome

molecular diagnostics

vaginal estrogen

lactobacillus crispatus

probiotics